RAPT THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.4 USD | +1.62% |
|
-46.86% | -82.29% |
| May. 10 | Guggenheim Downgrades RAPT Therapeutics to Neutral From Buy | MT |
| May. 10 | Barclays Downgrades RAPT Therapeutics to Equalweight, Price Target at $4 | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RAPT THERAPEUTICS, INC. | Bio Therapeutic Drugs | +1.62% | -46.86% | -82.29% | -76.82% | - | 151M |  | | |
- Stock Market
- Equities
- RAPT Stock
- Charts RAPT Therapeutics, Inc.
- Relative Strength Chart